Scarica l'app Stockscreener
82.24
7.38%
5.65
Pre-mercato:
83.00
0.76
+0.92%
Precedente Chiudi:
$76.59
Aprire:
$75.69
Volume 24 ore:
10.78M
Relative Volume:
1.66
Capitalizzazione di mercato:
$14.93B
Reddito:
$1.36B
Utile/perdita netta:
$-302.91M
Rapporto P/E:
-47.86
EPS:
-1.7182
Flusso di cassa netto:
$-219.93M
1 W Prestazione:
+2.34%
1M Prestazione:
+24.29%
6M Prestazione:
+68.42%
1 anno Prestazione:
+3.80%
Intervallo 1D:
$74.81
$82.46
Intervallo di 1 settimana:
$74.81
$82.46
Portata 52W:
$40.77
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, TXG, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
82.24 | 14.93B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
274.84 | 44.50B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
56.02 | 11.08B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
84.11 | 10.96B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
91.98 | 7.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-13 | Iniziato | Jefferies | Underperform |
| 2026-04-13 | Aggiornamento | TD Cowen | Hold → Buy |
| 2026-02-19 | Iniziato | Mizuho | Outperform |
| 2026-02-17 | Iniziato | Robert W. Baird | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-21 | Iniziato | BTIG Research | Buy |
| 2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Ripresa | TD Cowen | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-12-09 | Iniziato | Guggenheim | Buy |
| 2024-11-11 | Downgrade | Stifel | Buy → Hold |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-12 | Iniziato | Piper Sandler | Neutral |
| 2024-07-09 | Iniziato | BofA Securities | Buy |
| 2024-07-09 | Iniziato | JP Morgan | Overweight |
| 2024-07-09 | Iniziato | Longbow | Buy |
| 2024-07-09 | Iniziato | Loop Capital | Buy |
| 2024-07-09 | Iniziato | Morgan Stanley | Overweight |
| 2024-07-09 | Iniziato | Needham | Buy |
| 2024-07-09 | Iniziato | Stifel | Buy |
| 2024-07-09 | Iniziato | TD Cowen | Buy |
| 2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Leica biosystems integrates tempus AI into aperio AI store - news-medical.net
AI in Clinical Trials Market Set for Transformative Growth Through 2040, Unlocking Opportunities Across Trial Phases, Therapeutic Areas, End Users and Key Global Regions - GlobeNewswire Inc.
Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Company Stock - MarketBeat
RXRX Stock Rises As Tempus AI Deal Resets Growth Story - StocksToTrade
Tempus AI CEO-linked entities sell 250,000 shares - Stock Titan
Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know - TradingKey
Tempus AI (NASDAQ:TEM) Trading 6.1% HigherTime to Buy? - MarketBeat
Tempus AI Soars As Wall Street Bets On Data - TipRanks
Promising Artificial Intelligence Stocks To ConsiderSeptember 24th - MarketBeat
Tempus AI Chief Accounting Officer Sells $529,650 of Stock - The Globe and Mail
Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4 - finance.yahoo.com
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics - Investing.com
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics By Investing.com - Investing.com UK
Tempus AI, Inc. (TEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test - Insider Monkey
Tempus AI Stock Price: TEM Stock Chart, Market Cap & News Today - CoinGecko
Tempus AI (NASDAQ:TEM) Upgraded by The Goldman Sachs Group to Hold Rating - MarketBeat
Tempus AI: High Risk, But With A Great Cause (NASDAQ:TEM) - Seeking Alpha
Goldman Sachs initiates coverage of Tempus AI (TEM.US) with a Neutral rating: Diagnostic business to benefit from reimbursement tailwinds, while data contracts enter a "validation phase" - Moomoo
Tempus AI: Data And Applications Will Unlock More Upside (NASDAQ:TEM) - Seeking Alpha
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion - MarketBeat
Tempus AI Fails to Trim Guardant Lawsuit Over Diagnostic Tests - Bloomberg Law News
A data partnership shifts from potential $84 million in two-year fees to $42 million in committed payments over three - Stock Titan
Recursion Pharmaceuticals, Inc. Grants Tempus Ai, Inc. Non-Exclusive License for Rna Foundation Model - marketscreener.com
Tempus AI, Recursion Extend Data License, Amend Fee Structure - Moomoo
Tempus extends Recursion data partnership through 2029 By Investing.com - Investing.com Nigeria
Tempus AI: Market Is Hyping On An Uncertain Number (NASDAQ:TEM) - Seeking Alpha
Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model - Business Wire
Goldman Sachs initiates Tempus AI stock coverage with neutral rating By Investing.com - Investing.com Australia
Goldman Sachs Initiates Tempus AI at Neutral With $75 Price Target - Moomoo
Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Complex Terrain of Healthcare Innovation - DirectorsTalk Interviews
Tempus AI (TEM) Is Building a Heart Failure Agent That Never Sleeps - finance.yahoo.com
Tempus AI (TEM), What Is Behind The Latest Buzz? - finance.yahoo.com
What Is Tempus AI (TEM)? The $98.5M Mark Behind Q2 - Phemex
Tempus AI CEO Eric P. Lefkofsky sells $16.1 million of stock - Investing.com Nigeria
Tempus AI (TEM) Is Up 31.9% After Launching 100,000‑Genome AI Research Platform Initiative - finance.yahoo.com
Tempus AI EVP, Chief Legal Officer Andrew Polovin disposes of 2,951 common shares for $221,325 - Bitget
Tempus AI (TEM) Unveils Whole Genome Platform With Plans For 1 Million Genomes - finance.yahoo.com
Tempus AI’s EVP, chief legal officer, sells $221,325 in stock By Investing.com - Investing.com Canada
Tempus AI (TEM) Chief Accounting Officer Ryan Bartolucci Sells 7 - GuruFocus
Andrew Polovin Sells 2,951 Shares of Tempus AI (NASDAQ:TEM) Stock - MarketBeat
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 200,000 Shares - MarketBeat
Tempus AI chief accounting officer sells $529,650 in stock By Investing.com - Investing.com Nigeria
Tempus AI chief accounting officer sells $529,650 in stock - Investing.com
Tempus AI CEO, data Ryan Fukushima sells $49,000 in stock - Investing.com
Tempus AI CEO, data Ryan Fukushima sells $49,000 in stock By Investing.com - Investing.com South Africa
Tempus AI(TEM.US) 10% Shareholder Sells US$16.11 Million in Common Stock - Moomoo
Tempus AI (TEM) data chief’s spouse sells 700 shares under plan - Stock Titan
EVP at Tempus AI (TEM) sells shares in preset plan trade - Stock Titan
Tempus AI Pulls Back After 40% Rally as Analysts Question Valuation - finance.biggo.com
Tempus AI outlook: revenue growth and risks in focus By Investing.com - Investing.com Nigeria
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.43%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):